Search research articles
Contact Us
Filters
Showing results (911-920 of 942) with videos related to
Page
of 95
Sort By:
ACS Medicinal Chemistry Letters
|
December 21, 2016
Sulfonamides as Selective Na<sub>V</sub>1.7 Inhibitors: Optimizing Potency and Pharmacokinetics to Enable in Vivo Target Engagement
Isaac E Marx, Thomas A Dineen, Jessica Able, et al.
Brain : a Journal of Neurology
|
September 2, 2009
Molecular basis of infantile reversible cytochrome c oxidase deficiency myopathy
Rita Horvath, John P Kemp, Helen A L Tuppen, et al.
Brain : a Journal of Neurology
|
December 20, 2012
What is influencing the phenotype of the common homozygous polymerase-γ mutation p.Ala467Thr?
Vivienne C M Neeve, David C Samuels, Laurence A Bindoff, et al.
ACS Medicinal Chemistry Letters
|
April 17, 2024
Empowering Voices: Inspiring Women in Medicinal Chemistry
Maria-Jesus Blanco, Joanne J Bronson, Erin F DiMauro, et al.
American Journal of Human Genetics
|
October 15, 2013
Macrocytic anemia and mitochondriopathy resulting from a defect in sideroflexin 4
Gordon J Hildick-Smith, Jeffrey D Cooney, Caterina Garone, et al.
Journal of Medicinal Chemistry
|
October 20, 2023
Discovery of MK-1468: A Potent, Kinome-Selective, Brain-Penetrant Amidoisoquinoline LRRK2 Inhibitor for the Potential Treatment of Parkinson's Disease
Solomon D Kattar, Anmol Gulati, Kaila A Margrey, et al.
Journal of Medicinal Chemistry
|
March 8, 2024
Empowering Voices: Inspiring Women in Medicinal Chemistry
Maria-Jesus Blanco, Joanne J Bronson, Erin F DiMauro, et al.
Physical Review Letters
|
September 28, 2010
Auger electron angular distribution of double core-hole states in the molecular reference frame
James P Cryan, J M Glownia, J Andreasson, et al.
ACS Medicinal Chemistry Letters
|
March 25, 2017
Correction to "Sulfonamides as Selective Na<sub>V</sub>1.7 Inhibitors: Optimizing Potency and Pharmacokinetics to Enable <i>in Vivo</i> Target Engagement"
Isaac E Marx, Thomas A Dineen, Jessica Able, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 21, 2017
The discovery of benzoxazine sulfonamide inhibitors of Na<sub>V</sub>1.7: Tools that bridge efficacy and target engagement
Daniel S La, Emily A Peterson, Christiane Bode, et al.
Page
of 95
Search research articles
Search
Showing results (911-920 of 942) with videos related to
Sort By:
Page
of 95
ACS Medicinal Chemistry Letters
|
December 21, 2016
Sulfonamides as Selective Na<sub>V</sub>1.7 Inhibitors: Optimizing Potency and Pharmacokinetics to Enable in Vivo Target Engagement
Isaac E Marx, Thomas A Dineen, Jessica Able, et al.
Brain : a Journal of Neurology
|
September 2, 2009
Molecular basis of infantile reversible cytochrome c oxidase deficiency myopathy
Rita Horvath, John P Kemp, Helen A L Tuppen, et al.
Brain : a Journal of Neurology
|
December 20, 2012
What is influencing the phenotype of the common homozygous polymerase-γ mutation p.Ala467Thr?
Vivienne C M Neeve, David C Samuels, Laurence A Bindoff, et al.
ACS Medicinal Chemistry Letters
|
April 17, 2024
Empowering Voices: Inspiring Women in Medicinal Chemistry
Maria-Jesus Blanco, Joanne J Bronson, Erin F DiMauro, et al.
American Journal of Human Genetics
|
October 15, 2013
Macrocytic anemia and mitochondriopathy resulting from a defect in sideroflexin 4
Gordon J Hildick-Smith, Jeffrey D Cooney, Caterina Garone, et al.
Journal of Medicinal Chemistry
|
October 20, 2023
Discovery of MK-1468: A Potent, Kinome-Selective, Brain-Penetrant Amidoisoquinoline LRRK2 Inhibitor for the Potential Treatment of Parkinson's Disease
Solomon D Kattar, Anmol Gulati, Kaila A Margrey, et al.
Journal of Medicinal Chemistry
|
March 8, 2024
Empowering Voices: Inspiring Women in Medicinal Chemistry
Maria-Jesus Blanco, Joanne J Bronson, Erin F DiMauro, et al.
Physical Review Letters
|
September 28, 2010
Auger electron angular distribution of double core-hole states in the molecular reference frame
James P Cryan, J M Glownia, J Andreasson, et al.
ACS Medicinal Chemistry Letters
|
March 25, 2017
Correction to "Sulfonamides as Selective Na<sub>V</sub>1.7 Inhibitors: Optimizing Potency and Pharmacokinetics to Enable <i>in Vivo</i> Target Engagement"
Isaac E Marx, Thomas A Dineen, Jessica Able, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 21, 2017
The discovery of benzoxazine sulfonamide inhibitors of Na<sub>V</sub>1.7: Tools that bridge efficacy and target engagement
Daniel S La, Emily A Peterson, Christiane Bode, et al.
Page
of 95